NRXP

NASDAQ open

NRx Pharmaceuticals

2.17 USD
▼-0.38-14.90%
盘后 2.22 0.00%
2026-11-20
市值
$93.02M
市盈率
—
EPS
-0.56
股息率
—
52 周区间
1.62 – 5.06
成交量
962.64K
Beta
2.06
目标价
48.33
52W 低 1.6252W 高 5.06
价格走势

公司简介

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for in...